Parkervision INC

Market Movers (8-K)

OQB
ParkerVision, Inc. announced the retirement of director Lewis Titterton and the appointment of Anthony Bowers to the board, effective May 19, 2026.
OQB
ParkerVision announced its first quarter 2026 financial results, reporting a reduced net loss, while highlighting significant developments in its ongoing patent infringement litigation against major tech companies.
Delay expected
OQB
ParkerVision, Inc. has extended the expiration dates of stock options for its CEO and CFO to preserve long-term incentive value.
OQB
ParkerVision reported a reduced net loss for 2025, driven by changes in contingent payment obligations, while facing delays and appeals in key patent infringement lawsuits.
Worse than expected
Delay expected
Capital raise
OQB
ParkerVision, Inc. converted $675,000 in outstanding convertible promissory notes and $13,200 in accrued interest into 3,277,099 shares of common stock at an exchange price of $0.21 per share.
Capital raise
OQB
ParkerVision, Inc. announced new performance-based and time-based stock options for its CEO and CFO, alongside a 2.5% salary increase.

Quarterly Earnings (10-Q)

OQB
ParkerVision reports Q1 2026 results with no licensing revenue, a net loss of $1.6 million, and ongoing patent litigation, while addressing liquidity concerns.
Delay expected
Worse than expected
Capital raise
OQB
ParkerVision, Inc. reports a significant cash burn and ongoing liquidity challenges, raising substantial doubt about its ability to continue as a going concern, while key patent litigation faces further delays and appeals.
Delay expected
Worse than expected
Capital raise
OQB
ParkerVision, Inc. reported a significant increase in net loss and cash burn, raising substantial doubt about its ability to continue as a going concern.
Delay expected
Worse than expected
Capital raise
OQB
ParkerVision reports a net loss of $3.8 million for Q1 2025, highlighting the company's continued focus on patent enforcement and licensing.
Worse than expected
Capital raise
Delay expected
OQB
ParkerVision's Q3 2024 results show a net loss of $10.8 million and ongoing challenges with liquidity, despite a favorable ruling in a key patent litigation case.
Worse than expected
Capital raise
OQB
ParkerVision reported a net loss of $1.02 million for the first half of 2024, with ongoing patent litigation and financial challenges raising concerns about the company's ability to continue as a going concern.
Worse than expected
Delay expected
Capital raise

Annual Reports (10-K)

OQB
ParkerVision, Inc. reported significant losses and negative cash flows for fiscal year 2025, raising substantial doubt about its ability to continue as a going concern, as it continues to rely heavily on patent enforcement litigation for future revenue.
Worse than expected
Capital raise
Delay expected
OQB
ParkerVision's 2024 10-K filing reveals a $14.5 million net loss and highlights the company's focus on patent enforcement and licensing amid substantial doubt about its ability to continue as a going concern.
Capital raise
Worse than expected
OQB
ParkerVision Inc. achieved a net income of $9.5 million in 2023, primarily due to patent licensing revenue, but faces substantial doubt about its ability to continue as a going concern due to debt obligations and reliance on future patent enforcement proceeds.
Worse than expected
Delay expected
Capital raise

Insider Trading (Form 4)

OQB
PARKERVISION CEO Jeffrey Parker was granted 8 million performance-based stock options with a $0.24 exercise price, vesting over five years.
OQB
ParkerVision's Chief Financial Officer, Cynthia L. French, was granted 1,000,000 nonqualified stock options with an exercise price of $0.24 per share.
OQB
PARKERVISION Inc. Director Paul A. Rosenbaum was granted 370,000 stock options as compensation for his 2026 Board service.
OQB
PARKERVISION Director Lewis H Titterton Jr. received 370,000 stock options as compensation for 2026 Board service, exercisable at $0.24 per share and vesting over two years.
OQB
ParkerVision Director Robert Greene Sterne was granted 370,000 stock options as compensation for his 2026 Board service.
OQB
ParkerVision Director Lewis H. Titterton Jr. acquired over 4.7 million shares of common stock for $1 million, increasing his beneficial ownership.
Capital raise

Proxy Statements (Def-14A)

OQB
PARKERVISION, INC. submitted definitive additional proxy materials to the SEC, indicating no filing fee was required.
OQB
ParkerVision, Inc. announced its 2025 Annual Meeting of Shareholders to be held virtually on September 30, 2025, focusing on director elections, auditor ratification, and executive compensation votes.
Delay expected
Worse than expected
Capital raise
OQB
ParkerVision, Inc. has filed a definitive proxy statement with the SEC.
OQB
ParkerVision is asking shareholders to approve an amendment to increase the number of authorized common shares from 175 million to 225 million at the upcoming annual meeting.
Capital raise

Schedule 13D - Activist Investments

OQB
A director of ParkerVision Inc. significantly increased his beneficial ownership of common stock through recent purchases and option exercises, now holding 7.0% of the company.
Capital raise

Schedule 13G - Passive Investments

OQB
Gem Investment Advisors, Gem Partners, Flat Rock Partners, and Daniel M. Lewis report combined 9.99% stake in ParkerVision Inc. as of March 31, 2026.
OQB
Gem Investment Advisors, GEM PARTNERS LP, Flat Rock Partners LP, and Daniel M. Lewis have collectively disclosed beneficial ownership of 9.99% of PARKERVISION INC's common stock.